Juvenile polyposis (JP) was first distinguished from other gastrointes
tinal polyposis syndromes in 1964. Since then, some 272 cases of this
entity have been reported in the literature. The underlying polyps fou
nd in JP are of the hamartomatous type, but it is known that juvenile
polyps may contain adenomatous tissue, or may be accompanied by adenom
as. For the most part, juvenile polyps are found in the colon, but may
also develop in the stomach, duodenum, jejunum or ileum. In 20 to 50%
of the cases, juvenile polyposis occurs as a familial condition. Extr
a-intestinal anomalies are found in approximately 11% of JP patients.
A particular clinical feature is anaemia caused by chronic gastroitest
inal bleeding. In infants and young children, however, massive diarrho
ea may become life-threatening. A reported malignant degeneration rate
of 17.6% (among known cases) justifies the classification of JP as a
precancerous condition, and has both therapeutic and, in particular, p
rophylactic consequences. These include the need to carry out regular
follow-up examinations of the entire gastrointestinal tract, and also
screening examinations in other members of the family.